Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Ben J. Barnett, Medical School (MS), Gilead Sciences, $240,449, A Phase III, Randomized, Open-Label, Multi-Center Study of the Treatment of Antiretroviral-Naive, HIV-1 Infected Subjects Comparing Tenofovir Disoproxil Fumarate and Emtricitabine in Combination with Efavirenz vs. Combivir (Lamivudine/Zidovudine) and EFA.

Eric Boerwinkle, School of Public Health (SPH), Graduate School of Biomedical Sciences (GSBS) and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), Johns Hopkins University, $27,083, Admixture Mapping to Identify T2DM Genes in African Americans.

Deborah L. Brown, MS, Grifols Biologicals Inc., $59,773, A Phase II/III Pivotal Trial Evaluating the Safety, Pharmacokinetic Properties and Efficacy of a Plasma Derived Anti-Thrombin III Concentrate with Administration in Surgery, Pregnancy and Thromboembolic to Thrombotic Events.

Kimberly Napoli Eaton, MS, Research Oriented Biostatistics Inc., $54,502, IMX Sirolimus Assay, The University of Texas Medical School at Houston Loading Dose Study Protocol.

Nicole R. Gonzales, MS, University of Medicine & Dentistry of New Jersey, $105,754, Carotid Revascularization Endarterectomy vs. Stent Trial.

Carin A. Hagberg, MS, Hospira Inc., $85,185, A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Evaluating the Safety and Efficacy of Dexmedetomidine Used for Sedation during Elective Awake Fiberoptic Intubation.

Barry D. Kahan, MS and GSBS, Novartis Pharmaceuticals Corp., $10,000, The Division of Immunology and Organ Transplantation Annual Retreat.

John Mohr, MS, Astrazeneca, $42,597, Effect of Merepenem and Aztreonam with and without Variable Concentrations of Colistin on Metallo-B-Lactamase (Mbl) Producing Pseudomonas Aeruginosa.

Patricia Dolan Mullen, SPH, Texas Cancer Council, $90,000, A Utilization-Focus Evaluation of Three TCC-Funded Oncology Education Programs.

Kristy O. Murray, SPH, Oregon Health Sciences University, $79,633, West Nile Virus Infection and Immunity in the Elderly: Mechanisms of Vulnerability.

Cheryl L. Perry, SPH, University of Minnesota, $31,926, Minnesota Adolescent Community Cohort (MACC) Study.

Leslie Roeder, Dental Branch (DB), Dental Consultants Inc., $2,000, Gloss and Surface Roughness of Composites by Polishers.

Dhiren S. Sheth, MS, AO North America Inc., $5,000, The Effect of Nicotine on Enchondral Ossification vs. Primary Bone Healing in a Rabbit Experimental Model.

Rita D. Swinford, MS, Emmes Corporation, $2,226, North American Renal Transplant and Cooperative Study.

Nadarajah Vigneswaran, DB, UT M. D. Anderson Cancer Center, $50,000, Developmental Research Project: Role of Emmprin/CD147 in the Progression of Oral Premalignancies.

Z. Hong Zhou, MS and GSBS, University of Alabama at Birmingham, $32,943, Assembly of the Negative Stranded RNA Virus Core.

Renewal

Ann O. Cheek, SPH, UT Austin, $66,475, Individual Level Indicators: Reproductive Function in Estuarine Fishes.

M. Sriram Iyengar, School of Health Information Sciences, Universities Space Research Association, $106,374, Integrated Medical Model for Exploration Missions (Part 1).

Diane Persson, School of Nursing, City of Houston, $1,365,101, UT Ombudsman Program and Family Caregiver Program (response to RFP covers ombudsman, caregiver and training).

Jan M. Risser, SPH, City of Houston, $510,230, HIV Behavioral Surveillance in High Risk Heterosexual Population.

Transfer

Cheryl L. Perry, SPH, National Institutes of Health, $293,292, Mobilizing Youth for Action against Tobacco in India.